Valuation
- Market cap
- 4,465,000
- Revenue TTM
- $0
- Net income TTM
- $-7,560,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 29,500
- Avg volume
- 893,916
- Day's range
- $1.11 – $1.15
- Shares out
- 4,022,000
- Stochastic %K
- 37%
- Beta
- 0.66
- Analysts
- Strong Sell
- Price target
- $4.00
Company profile
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquar...
Show more
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 858 800 2543
- Website
- https://www.dermatarx.com
- Address
- 3525 Del Mar Heights Rd., Suite 332, San Diego, United States
Latest news
No headlines yet.
